Clinical pharmacology consultations: Consultation requests may be misleading - An organized approach to drug-induced hepatitis

Canadian Journal of Clinical Pharmacology

Volumn 10, Issue 2, 2003, Pages 59-62

  Valois, Maria ^a   Cooper, Mary Anne ^a   Shear, Neil H ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Adverse drug reaction; Dalteparin; Drug induced liver injury; Hepatitis; Liver toxicity; Ranitidine

Indexed keywords

AMINOTRANSFERASE; AMPICILLIN; BISACODYL; CEFAZOLIN; CEFOTETAN; CHLORAL HYDRATE; DALTEPARIN; DIMENHYDRINATE; DIPHENHYDRAMINE; FUROSEMIDE; GENTAMICIN; HALOPERIDOL; HEPARIN; KETOROLAC; METRONIDAZOLE; MORPHINE; OMEPRAZOLE; PARACETAMOL; RANITIDINE; WARFARIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONSULTATION; DRUG EXPOSURE; HEPATITIS; HUMAN; LIVER TOXICITY; MALE; TOXIC HEPATITIS;

EID: 0041931019     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Zimmerman HJ. Expressions of hepatotoxicity. In: Zimmerman HJ, ed. Hepatotoxicity. The Adverse Effect of Drugs and Other Chemicals on the Liver, 2nd edn. New York: Lippincott, Williams & Wilkins, 2000:61-109.
2. Prussick R, Knowles S, Shear NH. Cutaneous drug reactions. Curr Probl Dermatol 1994;6:81-124.
3. Lee W. Drug-induced hepatotoxicity. N Engl J Med 1995;333:1118-27.
4. Maria V, Virctorino R. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 1997;26:664-9.
5. Danan G, Benichou C. Causality assessment of adverse reactions to Drugs - I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. J Clin Epidemiol 1993;46:1323-30.
6. Benichou C, Danad G, Flahault A. Cauality assessment of adverse reactions to drugs - II. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge. J Clin Epidemiol 1993;46:1331-6.
7. Ribeiro J, Lucas M, Baptista A, Victorino R. Fatal hepatitis associated with ranitidine. Am J Gastroenterol 2000;95:559-60.
8. Cherqui B, Desaint B, Legendre C, et al. Hepatite mortelle chez une patiente traitee par la ranitidine. Gastroenterol Clin Biol 1989;13:952-3.
9. Souza Lima M. Hepatitis associated with ranitidine. Ann Intern Med 1984;101:207-8.
10. Hiesse C, Cantarovich M, Santelli C, Francais P, Charpentier B, Fries D. Ranitidine hepatotoxicity in renal transplant patient. Lancet 1985;i:1280.
11. Barr G, Piper D. Possible ranitidine hepatitis. Med J Aust 1981;2:421.
12. Ramrakhiani S, Brunt E, Bacon B. Possible cholestatic injury from ranitidine with a review of the literature. Am J Gastroenterol 1988;93:822-6.
13. Offit K, Sojka D. Letter to the Editor. N Engl J Med 1984;310:1603-4.
14. Black M, Scott WJ, Kanter R. Possible ranitidine hepatotoxicity. Ann Intern Med 1984;101:208-10.
15. Souza Lima M. Ranitidine and the liver. Ann Intern Med 1985;102:273-4.
16. Proctor J. Hepatitis associated with ranitidine. JAMA 1984;251:1554.
17. Bredfeldt J, von Huene C. Ranitidine, acetaminophen, and hepatotoxicity. Ann Intern Med 1984;101:719.
18. Speeg KJ, Christian D. Ranitidine and acetaminophen hepatotoxicity. Ann Intern Med 1984;100:315-6.
19. Lauristsen K, Havelund T, Rask-Maden J. Ranitidine and hepatotocity. Lancet 1984;ii:1471.
20. Karachalios G. Ranitidine and hepatits. Ann Intern Med 1985;103:634-5.
21. Souza Lima M. Ranitidine and hepatic injury. Ann Intern Med 1986;105:140.
22. Dobbs J, Muir J. Hz-antagonists and hepatitis. Ann Intern Med 1986;105:803.
23. Halparin L. Adverse effects of rantidine therapy. Can Med Assoc J 1984;130:668-72.